ConductScience.org, home

Gene · 7913

NIH grants1,044

NIH grants whose papers are about the gene, through NIH's grant-paper links.

221 to 240 of 1,044

Download this page as JSON
GrantTitleDEK papersNewest fiscal year
ZIABC011850Genomic Biomarkers of Cancer12025
ZIABC011978Developmental and Homeostatic origins of cancer12025
ZIADE000719Cell-Surface Interactions in Pathogenesis12025
ZIADK015600Drosophila Functional Genomics12025
ZIADK036119Structural and mechanistic studies Of DNA mismatch repair12025
ZIADK054514Investigation of management and disease manifestations of viral hepatitis12025
ZIADK075150Management and Treatment of Chronic Delta Hepatitis Infection and other Liver Diseases12025
ZIAHD008954Mitotic roles of the Nuclear Transport Machinery12025
ZIAHL006126Centrosome Regulation in Development and Dysregulation in Disease12025
ZIASC010357Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses12025
ZICAG000616Analysis of complex biological systems by high-throughput genomic technologies12025
ZICAR041207High Throughput Next Generation Sequencing, Single-Cell Omics and Spatial Transcriptomic: supports genomics and epigenomics research in muscle, skin, bone and autoimmune diseases12025
ZICBC010687Histology Core Laboratory12025
ZICBC012129Mechanisms of olfactory neuroblastoma tumorigenesis12025
T32GM007863Michigan Medical Scientist Training Program92024
T32ES007250Environmental Carcinogenesis and Mutagenesis52024
R01DK046865Function of Putative Determinant in Hematopoiesis32024
R37CA218072Mechanisms coupling DEK to oncogenesis32024
KL2TR001426KL2 Training Program22024
R01CA239697Defining genetic and metabolic requirements of aggressive breast cancer22024

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/7913/grants?page=12